INGN FY 2025 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$349M+3.9% YoY

Gross Profit

$166M47.6% margin

Operating Income

-$30M-8.7% margin

Net Income

-$23M-6.5% margin

EPS (Diluted)

$-0.85

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$22M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$299M

Total Liabilities

$106M

Stockholders' Equity

$192M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$349M	$336M	+3.9%
Gross Profit	$166M	$155M	+7.2%
Operating Income	-$30M	-$43M	+29.0%
Net Income	-$23M	-$36M	+36.6%